|
|||||||||||||||||||
Betaferon Efficacy
|
MS Gateway - a portal for MS patients and their relatives ... Betaferon® efficacy The importance of efficacy. Betaferon ® is a first-line therapy for MS that works fast to help control ... http://www.ms-gateway.com/more-on-betaferonreg/betaferonreg-efficacy-147.htmEfficacy of Betaseron/Betaferon in Relapsing-Remitting Multiple Sclerosis: Trial Name: Brief Description: Results: Reference: IFNB Multiple Sclerosis Study Group - IFN b-1b (Betaseron ... http://www.mult-sclerosis.org/Betaseron.htmlBetaferon® (interferon beta-1b) significantly delays the development of confirmed disability progression and the development of clinically definite multiple sclerosis (MS) in ... http://www.medicalnewstoday.com/articles/85443.phpBEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients http://clinicaltrials.gov/ct2/show/NCT00099502BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose. Information source: Bayer Information obtained from ClinicalTrials.gov on June 20, 2008 http://www.druglib.com/trial/02/NCT00099502.htmlBEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose (Beyond) http://clinicaltrials.gov/ct2/show/NCT00459667Betaferon: One 3 mL vial contains interferon beta-1b 9,6 million IU ... development of neutralising activity is associated with a reduction in clinical efficacy ... http://home.intekom.com/pharm/schering/betafern.htmlINCOMIN data showing superior efficacy of Betaferon/Betaseron vs. Avonex. ... find Biotech Week articles. div id="be-doc-text" 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Schering ... http://www.highbeam.com/doc/1G1-86476509.htmlBetaferon® Until the ?60s, very little was known about MS and how to treat it ... of a great deal of data confirming the long term benefits, efficacy and safety of Betaferon® in many ... http://www.ms-gateway.com/more-on-betaferonreg-144.htm2007-10-12 Results of Landmark BENEFIT Study presented at ECTRIMS: Betaferon® treatment delays disability in early MS; strong efficacy not affected by neutralizing antibodies http://www.viva.vita.bayerhealthcare.com/index.php?id=36&type=100&no_cache=1&tx_ttnews[tt_news]=12092&tx_ttnews[backPid]=36Sixteen-Year Follow-up Study Reinforces Betaferon Long-Term Efficacy, Safety and Tolerability in Multiple Sclerosis http://www.viva.vita.bayerhealthcare.com/index.php?id=386&tx_ttnews[tt_news]=11193&cHash=05b1958df6Please contact the Account Manager for opportunities with this organisation http://www.zenopa.com/news/19831506/Bayer_Schering_Pharma_reports_long_term_efficacy_of_BetaferonINCOMIN data showing superior efficacy of Betaferon/Betaseron vs. Avonex. - 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Schering AG announced : Encyclopedia.com http://www.encyclopedia.com/doc/1G1-86476509.htmlThe approval is based on established efficacy and safety data from pivotal Betaferon clinical trials, along with findings from a single-arm study designed to demonstrate the ... http://insciences.org/article.php?article_id=7761In addition to evaluating the new, higher Betaferon® dose, one of the treatment arms in BEYOND will compare Betaferon® with glatiramer acetate -- the first time efficacy of an ... http://www.thisisms.com/article-print-14.htmlPatients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with ... http://betaseron.com/?Betaferon® is the MS drug with the longest clinical experience of more than 16 years. The product offers both unsurpassed efficacy and long-term reliable safety in relapsing ... http://pharma.bayer.com/scripts/pages/en/news_room/news_room/news_room38.phpBetaferon® treatment delays disability in early MS; strong efficacy not affected by neutralizing antibodies Betaferon® (interferon beta-1b) significantly ... http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1766BEYOND adds support to the BENEFIT findings in that it demonstrated that Betaferon® 250mcg is the optimal dose for the treatment-naïve patient population due to high efficacy and ... http://www.drugs.com/clinical_trials/beyond-study-results-do-not-support-regulatory-filing-betaferon-500-mcg-2470.htmlBEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose https://www.healogica.com/trials/multiple_sclerosis/NCT00459667/Additionally, the BEYOND study compares the efficacy of Betaferon(R) with glatiramer acetate (a non-interferon) in patients with RRMS. This will be the first head to head ... http://www.redorbit.com/news/health/180782/schering_ag_completes_recruitment_for_largest_ever_controlled_clinical_study/index.htmlThe results showed that both the approved Betaferon dose and ... Dose-response: European-North American Comparative Efficacy ... http://www.msassociation.org/news_center/article.asp?a=1"These results from the independent INCOMIN study clearly suggest that treatment of Multiple Sclerosis should begin with a regimen of high dose, high frequency treatment such as ... http://www.acceleratedcure.org:8080/node/75The BEYOND (Betaferon Efficacy Yielding Outcomes of a New Dose) study with 2,244 patients was to investigate the efficacy, tolerability and safety of a 500 mcg dose of Betaferon ... http://www.reuters.com/article/idUSL2923113720071029BEYOND: Betaferon/Betaseron efficacy yielding outcomes of a new dose in Multiple Sclerosis (MS) Patients : Trial ID: 91162 : The purpose of this study is to determine - whether ... http://www.bayerhealthcare.com/scripts/pages/en/research_development/clinical_trials/trial_finder/detail.php?trialid=91162&select_condition=&select_status=&select_location=&select_drug=&no_cache=1 |
|